Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
095700 | KO
Overview
Corporate Details
- ISIN(s):
- KR7095700001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크, 강서구
- Website:
- http://www.genexine.com/
- Sector:
- Manufacturing
Description
Genexine, Inc. is a clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation biologics. The company utilizes its proprietary hyFc® platform technology to create long-acting protein therapeutics. Its pipeline is led by GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for immuno-oncology applications. Other key assets in late-stage clinical trials include GX-E4, a long-acting treatment for anemia, and GX-H9 for growth hormone deficiency. Genexine's research and development efforts primarily target oncology and rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-27 00:00 |
투자판단관련주요경영사항(임상시험계획자진취하등)(GX-E4(빈혈치료제)의 국내 제 3상 임상시험계획(IND)신청 자진취하)
|
Korean | 11.5 KB | ||
| 2023-09-27 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청)(GX-E4(빈혈치료제)의 국내 제 3상 임상시험계획(IND) 승인신청)
|
Korean | 10.2 KB | ||
| 2023-09-04 00:00 |
투자판단관련주요경영사항(임상시험계획자진취하등)(GX-G8(단장증후군 치료제)임상 1상 시험 자진중단)
|
Korean | 12.4 KB | ||
| 2023-08-24 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청)(GX-E4(빈혈치료제)의 국내 제 3상 임상시험계획(IND) 승인신청)
|
Korean | 8.9 KB | ||
| 2023-08-14 00:00 |
반기보고서 (2023.06)
|
Korean | 1.7 MB | ||
| 2023-06-28 00:00 |
타법인주식및출자증권처분결정
|
Korean | 9.3 KB | ||
| 2023-06-28 00:00 |
신규시설투자등
|
Korean | 7.7 KB | ||
| 2023-06-28 00:00 |
타인에대한담보제공결정
|
Korean | 19.6 KB | ||
| 2023-06-27 00:00 |
[기재정정]투자판단관련주요경영사항(GX-E4(지속형 빈혈 치료제)기술이전 계약체결)
|
Korean | 17.0 KB | ||
| 2023-05-15 00:00 |
분기보고서 (2023.03)
|
Korean | 1.7 MB | ||
| 2023-05-03 00:00 |
기타경영사항(자율공시)(제6회차 전환사채 취득 후 재매각)
|
Korean | 7.9 KB | ||
| 2023-05-03 00:00 |
전환청구권행사
|
Korean | 10.5 KB | ||
| 2023-03-30 00:00 |
정기주주총회결과
|
Korean | 22.3 KB | ||
| 2023-03-20 00:00 |
감사보고서제출
|
Korean | 24.7 KB | ||
| 2023-03-20 00:00 |
사업보고서 (2022.12)
|
Korean | 2.0 MB |
Automate Your Workflow. Get a real-time feed of all Genexine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genexine, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genexine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
